Currencies37821
Market Cap$ 2.56T-0.70%
24h Spot Volume$ 36.59B+1.32%
DominanceBTC57.46%+0.35%ETH9.49%+0.71%
ETH Gas0.17 Gwei
Cryptorank
/

Intel Stock Forecast: Is $50 Support the Floor for INTC?


Intel Stock Forecast: Is $50 Support the Floor for INTC?

Share:

AI Overview

Intel shares at $51.47 on Apr 6, reclaiming $48.50 support; short‑term resistance $52 with an upside target of $53.50; 50‑day MA $46.16, avg vol ~45M, RSI 57; Q1 earnings due Apr 23. Company to buy Apollo’s 49% stake in Fab 34 for $14.2B, increasing manufacturing capacity—potential indirect impact on crypto hardware supply and infrastructure (mining/servers) but no direct DeFi/DEX/CEX or token launch linkage. Financial risks remain: EPS -$0.06, P/E -857, market cap $257B; mixed price forecasts (Trading Economics $41.84 q‑end, $38.18 1y; LongForecast $45.99 month, $62.91 high); earnings could drive volatility.

Bearish

Predictions Markets

See what traders are focused on

View analytics →
Prediction Banner

Intel is generating buzz as it climbs toward key resistance levels just weeks before its first-quarter earnings on April 23. The stock traded between $50.85 and $52.38 on April 6, closing at $51.47, up 2.16% from the previous session and well above its 50-day moving average of $46.16. That marks a solid rebound from recent lows near $48.50, but the market remains split on whether this is the start of a sustained uptrend or just short-term momentum.

Recent catalysts have helped the mood. On April 1, Intel announced it would repurchase Apollo’s 49% stake in the Fab 34 joint venture in Ireland for $14.2 billion, a move that signals confidence in its manufacturing expansion and could free up strategic flexibility. The timing also aligns with positive technical developments: INTC reclaimed the $48.50 support level, shifting the next upside target to $53.50, according to recent analysis.

Year-to-date, the stock is up significantly from its 2026 low of $17.67, though it remains far from its yearly high of $54.60.

What the chart shows

The price action looks encouraging in the short term. Intel has posted steady gains since early April, moving from $49.75 on April 1 to $51.47 today, with volume averaging around 45 million shares daily . That suggests buyers are stepping in, but the rally needs to hold above $50 to confirm strength.

A drop back below that level could test support near $48 again, especially if broader market sentiment sours.

Longer-term forecasts vary widely. Trading Economics sees INTC at $41.84 by quarter-end and $38.18 in a year, while more bullish views from LongForecast project $45.99 by April’s end and potential highs near $62.91. Technical indicators like RSI at 57 and positive MACD support further upside, though a pullback remains possible.

Key risks ahead

Earnings will be pivotal. Intel’s server CPUs for 2026 are reportedly “sold out,” and its new Panther Lake chips on the 1.8nm process show progress against rivals like TSMC. Still, with a negative EPS of -$0.06 and a P/E ratio of -857, valuation concerns linger. The stock’s market cap sits at $257 billion, leaving room for volatility if results disappoint.

For traders, $52 resistance is the line in the sand. A break above opens $53.50, while failure keeps the range intact. Intel’s repair looks real, but confirmation comes post-earnings.

Read the article at Coinpaper

In This News

Predictions Markets

See what traders are focused on

View analytics →
Prediction Banner

Share:

In This News

Predictions Markets

See what traders are focused on

View analytics →
Prediction Banner

Share:

Read More

Coinkite Launches Coldcard MK5: Major UX Upgrades to Flagship Bitcoin Hardware Wallet

Coinkite Launches Coldcard MK5: Major UX Upgrades to Flagship Bitcoin Hardware Wallet

Bitcoin Magazine Coinkite Launches Coldcard MK5: Major UX Upgrades to Flagship Bitco...
SPCE Stock Forecast: Virgin Galactic Surges 22% as SpaceX IPO Flight Tests Ignite Rally

SPCE Stock Forecast: Virgin Galactic Surges 22% as SpaceX IPO Flight Tests Ignite Rally

Virgin Galactic stock surged after flight testing resumed, legal risks eased, and Spa...